Cargando…

SARS-CoV-2 Vaccination: What Can We Expect Now?

Detalles Bibliográficos
Autores principales:	Meurens, François, Renois, Fanny, Bouin, Alexis, Zhu, Jianzhong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319792/ https://www.ncbi.nlm.nih.gov/pubmed/35891257 http://dx.doi.org/10.3390/vaccines10071093

Ejemplares similares

SARS-CoV-2 pandemic in India: what might we expect?
por: Gautam, Sneha, et al.
Publicado: (2020)

SARS-CoV-2 Vaccines: Where Are We Now?
Publicado: (2021)

SARS-CoV-2 Vaccines: Where Are We Now?
por: Flanagan, Katie L., et al.
Publicado: (2021)

Modelling Covid-19 under uncertainty: what can we expect?
por: Wang, Meimei, et al.
Publicado: (2020)

Effects of SARS Cov-2 epidemic on the obstetrical and gynecological emergency service accesses. What happened and what shall we expect now?()
por: Dell’Utri, Chiara, et al.
Publicado: (2020)

SARS-CoV-2 vs. Hepatitis Virus Infection Risk in the Hemodialysis Population: What Should We Expect?
por: D’Marco, Luis, et al.
Publicado: (2021)

Teleneurorehabilitation in the COVID-19 Era: What Are We Doing Now and What Will We Do Next?
por: Calabrò, Rocco Salvatore
Publicado: (2021)

Omicron SARS-CoV-2 variant: What we know and what we don’t
por: Ferré, Valentine Marie, et al.
Publicado: (2022)

Potential implications of SARS-CoV-2 epidemic in Africa: where are we going from now?
por: Torti, Carlo, et al.
Publicado: (2020)

COVID-19 and Dialysis Units: What Do We Know Now and What Should We Do?
por: Ikizler, T. Alp
Publicado: (2020)

SARS-CoV-2 vaccination in heart transplantation: What we do and do not know
por: Aslam, Saima, et al.
Publicado: (2022)

Chronic Kidney Disease—How Does It Go, and What Can We Do and Expect?
por: Chang, Li-Yun, et al.
Publicado: (2023)

Liver injury in COVID-19: What do we know now?
por: Yang, Hua-Yu, et al.
Publicado: (2020)

Now We Are Six
por: Hotez, Peter J., et al.
Publicado: (2012)

Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Reversal Agents: What We Have and What We Can Expect
por: Ruff, Christian T.
Publicado: (2018)

The COVID-19 surge in Indonesia: what we learned and what to expect
por: Tenda, Eric Daniel, et al.
Publicado: (2021)

SARS‐CoV‐2 vaccine clinical efficacy in SOT: What we know and our current gaps
por: Sigler, Rachel, et al.
Publicado: (2022)

Erratum to: Pneumococcal vaccination: what have we learnt so far and what can we expect in the future?
por: Torres, A., et al.
Publicado: (2014)

Arterial Stiffness—What Do We Know about It and What Do We Expect from This Biomarker?
por: Reiner, Željko
Publicado: (2022)

Flu RNA Vaccine: A Game Changer?
por: Meurens, François
Publicado: (2020)

Where are we now and where are we headed?
por: Langan, Ewan A.
Publicado: (2023)

Consistency, now what?
por: Terry, Mary Beth
Publicado: (2017)

NIPPV: Where Are We Now?
por: Fakharian, Atefeh, et al.
Publicado: (2013)

We Need to Know … Now!
por: Wojtys, Edward M.
Publicado: (2012)

We need to act now
por: Eisen, Michael B
Publicado: (2020)

What can we expect from first-generation COVID-19 vaccines?
por: Peiris, Malik, et al.
Publicado: (2020)

Disease-modifying agents in osteoarthritis: where are we now and what does the future hold?
por: Makaram, Navnit S., et al.
Publicado: (2023)

Should we vaccinate children against SARS-CoV-2?
por: The Lancet Infectious Diseases
Publicado: (2021)

The SARS-CoV-2, tears, and ocular surface debate: What we know and what we need to know
por: Ali, Mohammad Javed
Publicado: (2020)

Ketamine plus Alcohol: What We Know and What We Can Expect about This
por: Kobayashi, Natalia Harumi Correa, et al.
Publicado: (2022)

Intracranial Atherosclerosis: Where Are We Now?
por: Kim, Jong S.
Publicado: (2017)

Mindfulness in psychiatry – where are we now?
por: Groves, Paramabandhu
Publicado: (2016)

Hepatocellular adenoma: Where are we now?
por: Wang, Xi, et al.
Publicado: (2022)

Crop Improvement: Where Are We Now?
por: Sourdille, Pierre, et al.
Publicado: (2022)

What Now for Coronary Prevention?
por: Kirby, Brian J.
Publicado: (1979)

Major Persistent 5′ Terminally Deleted Coxsackievirus B3 Populations in Human Endomyocardial Tissues
por: Bouin, Alexis, et al.
Publicado: (2016)

Risk prediction of recurrent venous thrombosis; where are we now and what can we add?
por: Timp, Jasmijn F., et al.
Publicado: (2019)

Azithromycin and SARS-CoV-2 infection: Where we are now and where we are going
por: Parra-Lara, Luis Gabriel, et al.
Publicado: (2020)

New Variants in SARS-CoV-2: What are we Learning from the Omicron Variant?
por: Galán, Juan Carlos, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jer93pgjqekfc3f4ts0t8tpf80